Stay updated on Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial
Sign up to get notified when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.

Latest updates to the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a platform/software update for the page. This change signals an underlying update rather than any modification to the study details or results.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now shows a new revision label, v3.5.4, replacing the previous v3.5.3. This indicates an update to the page’s versioning metadata.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3 without changing the displayed study details.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check69 days agoChange DetectedThe Italian site entry changes from Padua to Padova (35128).SummaryDifference0.0%

- Check84 days agoChange DetectedNaples, Italy, 80131 was added in place of Napoli, Italy, 80131. The page revision changed from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.